Our Approach

We believe that care for individuals with autoimmune encephalitis begins at symptom onset and continues through the chronic phases of the disease. Early in the course of the disease, patients may require more extensive immunotherapy. However, as the disease progresses, a patient’s needs may shift to managing more long-standing neurologic and psychiatric manifestations.

At the Yale Autoimmune Encephalitis Program, we guide our patients through illness from the initial diagnosis and treatment to long-term management. As the field evolves, we are committed to advancing our understanding of the disease and improving treatments for our patients. We work closely with a network of scientists and physicians to fuel discovery and advance therapeutics.

Led by Tova Gardin, MD, MPP, a neuroimmunologist experienced in neurologic and psychiatric disease, the Autoimmune Encephalitis Program brings together clinicians, scientists, and allied specialties to provide holistic, person-centered care and to drive forward groundbreaking discoveries that serve our patients.